Gastroenterology division, Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, 10700, Thailand
NCT Number: NCT02219568
The purpose of this study is to compare the efficacy between video capsule endoscopy and CT enterography in diagnosis of obscure gastrointestinal bleeding.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bangkok, 10700, Thailand
All adult patients with obscure gastrointestinal bleeding will undergo both video capsule endoscopy and CT enterography. The interval between two tests will be less than 1 month. The capsule reading gastroenterologist and the CT reading radiologist are blinded to each others' results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CT enterography is performed using 64-channel multi-detector row CT scanners (Siemens Sensation 64, Siemens Medical solution, Forchiem, Germany). Prior to the scan, 1500 cc of a neutral oral-enteric contrast material, polyethylene glycol (NIFLEC) is taken by the patient. During the scan, 2cc/kg of intravenous contrast (iohexol, Ominipaque Amersham GE-Health care, Princeton, NJ) is injected at the velocity 5 cc/sec.
Video capsule endoscopy is performed using PillCam SB (Given Imaging, Yokneam, Israel). Polyethylene glycol (NIFLEC) is used for bowel preparation.
Time frame: up to 1 month
Significant gastrointestinal lesions are ulcers, mucosal inflammation, angiodysplasia, and mass.
Mahidol University
Other
Efficacy of Wireless Capsule Endoscopy and CT Enterography in Obscure Gastrointestinal Bleeding : Prospective Blinded Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02467621
Bacterial Infections, Bacterial Infections and Mycoses
Aalborg, Denmark
View Trial DetailsNCT03540368
Digestive System Diseases, Gastrointestinal Bleeding
Jakarta Pusat, DKI Jakarta, Indonesia
View Trial DetailsNCT06441201
Digestive System Diseases, Gastrointestinal Bleeding
Rochester, Minnesota, United States
View Trial DetailsNCT07025941
Acute Kidney Injury, Acute Kidney Injury (AKI)
Taizhou, Jiangsu, China
View Trial Details